Literature DB >> 3973404

Characterization of adenosine deaminase from normal human epidermis and squamous cell carcinoma of the skin.

H Koizumi, H Iizuka, T Aoyagi, Y Miura.   

Abstract

We compared the characteristics of adenosine deaminases (ADs) (E.C. 3.5.4.4.) in squamous cell carcinoma and normal human epidermis. Increased specific activity (per mg protein) of AD was observed in squamous cell carcinoma compared with that of the normal epidermis. In normal human epidermis most of the AD existed as a large form (Mr 300,000-350,000, type A). Squamous cell carcinoma of the skin was characterized by a high proportion of small-form (Mr 30,000-40,000, type C) AD. The proportion of the small-form enzyme varied from tumor to tumor. Comparison of the large-form AD from squamous cell carcinoma to that from normal epidermis revealed that both enzymes were similar in relative substrate specificity, Km values for adenosine, pH optima, heat stability pattern, isoelectric point, and sensitivity to inhibition by coformycin, a tight binding inhibitor of AD. However, the low molecular weight of AD from squamous cell carcinoma was less heat stable than that from the large-molecular-weight form. Increased AD activity and the high proportion of the small form of AD might be significant features of squamous cell carcinoma of the skin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3973404     DOI: 10.1111/1523-1747.ep12264833

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  6 in total

1.  Antigenicity of UV radiation-induced murine tumors correlates positively with the level of adenosine deaminase activity.

Authors:  S L Aukerman; I J Fidler
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

2.  Activities of adenosine deaminase, 5'-nucleotidase, guanase, and cytidine deaminase enzymes in cancerous and non-cancerous human breast tissues.

Authors:  O Canbolat; I Durak; R Cetin; M Kavutcu; S Demirci; S Oztürk
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  Evaluation of serum adenosine deaminase and 5'-nucleotidase activities as probable markers in ovarian cancer.

Authors:  P Pragathi; P V Bharath Kumar; P Amar Kumar; M Ramakanth Reddy; V Sravani; J Neeraja; Eapen Reeba Mary; K Gopalakrishna
Journal:  Indian J Clin Biochem       Date:  2005-07

4.  Adenosine deaminase, 5'-nucleotidase, xanthine oxidase, superoxide dismutase, and catalase activities in gastric juices from patients with gastric cancer, ulcer, and atrophic gastritis.

Authors:  I Durak; N Ormeci; O Akyol; O Canbolat; M Kavutçu; M Bülbül
Journal:  Dig Dis Sci       Date:  1994-04       Impact factor: 3.199

5.  Serum adenosine deaminase activity in brain tumours.

Authors:  S Manjula; A Raja; S N Rao; A R Aroor; A Rao
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

6.  Biochemical characterization of adenosine deaminase (CD26; EC 3.5.4.4) activity in human lymphocyte-rich peripheral blood mononuclear cells.

Authors:  L R Costa; A K Y de Souza; J N Scholl; F Figueiró; A M O Battastini; J A Dos Santos Jaques; F F Zanoelo
Journal:  Braz J Med Biol Res       Date:  2021-05-24       Impact factor: 2.590

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.